News
To sponsor this category, click here | subscribe to this category

Why are more people going online for health information ? Just look at the headlines

According to Pew Internet the overwhelming majority of Americans (92%) use multiple platforms to get news on a typical day, including national TV, local TV, the internet, local newspapers, radio, and national newspapers. Some 46% of Americans say they get news from four to six media platforms on a typical day

The Line Between Media and Social Media is Rapidly Blurring

Remember when your cell phone was just a cell phone?

Novelos shares hammered after Ph3 fiasco

Novelos (NVLT) announced this morning that its pivotal Phase III trial for its lead product–NOV-002–failed to hit the primary endpoint. Investors bailed quickly on the news, with the developer’s shares dropping 81 percent, hitting a 52-week low of 30 cents a share

Is Congress the New FDA?

Given the dismal track record of the U.S. Senate in the 111th Congress in producing important legislation to improve the lives of Americans, it appears that some of that body's members are looking for new things to do.

Gilead shares rise on HIV combo data

Shares of Gilead Sciences moved up yesterday

Healthcare legistlation is needed NOW

The stories of people who have been denied health insurance coverage or have had their policies cancelled are all over the news.

Become a Fan! Shouldn’t FDA Have a Facebook Page?

The FDA has made a clear effort at promoting transparency and engaging consumers more directly with its Transparency Initiative and in putting out requests to get input from the public, such as the recent Part 15 meetings on social media.

Poniard unveils staff cuts, new CEO in restructuring

Faced with a series of disappointing trial results for its cancer drug picoplatin, a cash-strapped Poniard Pharmaceuticals has opted to axe more than half of its staff and named a new CEO to replace Jerry McMahon, who is staying on as nonexecutive chairman. South San Francisco-based Poniard tapped COO Ronald Martell to become CEO and appointed Michael Perry as chief medical officer.

Crowdsourcing Vs. Science

I think the elevation of “crowdsourcing” as a legitimate indication for determining drug benefits or risks in the real world is a luddite-like anti-science trend that must be counteracted. The latest example of this was just published on the Dose of Digital blog in the post “The Best Pharma Products According to Patients”

The Functional Role of Social Media in Health Care